50 related articles for article (PubMed ID: 32800574)
1. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study.
Zheng J; He B; Deng L; Zhu X; Li R; Chen K; Zheng C; Wang D; Wang Y; Yu C; Chen G
Asia Pac J Clin Oncol; 2024 Apr; 20(2):275-284. PubMed ID: 36748794
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma.
Yanagaki M; Onda S; Gocho T; Igarashi Y; Shirai Y; Okui N; Matsumoto M; Sakamoto T; Haruki K; Ikegami T
Langenbecks Arch Surg; 2024 Apr; 409(1):130. PubMed ID: 38634913
[TBL] [Abstract][Full Text] [Related]
5. Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Kim HW; Lee JC; Paik KH; Lee YS; Hwang JH; Kim J
Medicine (Baltimore); 2015 Jun; 94(25):e1012. PubMed ID: 26107667
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer, radiomics and artificial intelligence.
Marti-Bonmati L; Cerdá-Alberich L; Pérez-Girbés A; Díaz Beveridge R; Montalvá Orón E; Pérez Rojas J; Alberich-Bayarri A
Br J Radiol; 2022 Sep; 95(1137):20220072. PubMed ID: 35687700
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic ductal adenocarcinoma: CEUS characteristics are correlated with pathological findings and help predict early recurrence after resection.
Wang L; Wang G; Wang P; Nie F
J Clin Ultrasound; 2024; 52(3):230-240. PubMed ID: 38018362
[TBL] [Abstract][Full Text] [Related]
8. Rim Enhancement on Contrast-Enhanced CT as a Predictor of Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
Yamaguchi T; Sofue K; Ueshima E; Sugiyama N; Yabe S; Ueno Y; Masuda A; Toyama H; Kodama T; Komatsu M; Hori M; Murakami T
Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667428
[TBL] [Abstract][Full Text] [Related]
9. Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysis.
Damm M; Efremov L; Jalal M; Nadeem N; Dober J; Michl P; Wohlgemuth WA; Wadsley J; Hopper AD; Krug S; Rosendahl J
United European Gastroenterol J; 2023 Dec; 11(10):998-1009. PubMed ID: 37987099
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Cationic Amphiphilic Antihistamines on Outcomes of Patients with Pancreatic Ductal Adenocarcinoma.
Chiang CH; Chiang CH; Hsia YP; Chen BS; Jaroenlapnopparat A; Chiang CH; Peng CM
J Gastrointest Cancer; 2024 Mar; 55(1):175-177. PubMed ID: 37707624
[TBL] [Abstract][Full Text] [Related]
11. Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.
Xia C; Qu JR; Jiao YP; Lu CQ; Zhao B; Ge RJ; Qiu Y; Cao BY; Yu Q; Xia TY; Meng XP; Song Y; Zhang LH; Long XY; Ye J; Ding ZM; Cai W; Ju SH
Eur Radiol; 2024 May; ():. PubMed ID: 38750169
[TBL] [Abstract][Full Text] [Related]
12. Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study.
Zaid M; Widmann L; Dai A; Sun K; Zhang J; Zhao J; Hurd MW; Varadhachary GR; Wolff RA; Maitra A; Katz MHG; Herman JM; Wang H; Knopp MV; Williams TM; Bhosale P; Tamm EP; Koay EJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291471
[TBL] [Abstract][Full Text] [Related]
13. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma.
Torphy RJ; Wang Z; True-Yasaki A; Volmar KE; Rashid N; Yeh B; Anderson JM; Johansen JS; Hollingsworth MA; Yeh JJ; Collisson EA
JCO Precis Oncol; 2018; 2018():. PubMed ID: 30506016
[TBL] [Abstract][Full Text] [Related]
14. Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
Singh I; Chou JF; Capanu M; Park J; Yu KH; Varghese AM; Park W; Zervoudakis A; Keane F; Rolston VS; Gerdes H; Wei AC; Shah P; Covey A; Schattner M; O'Reilly EM
Pancreatology; 2024 May; ():. PubMed ID: 38749803
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Investigation of the Efficacy and Indications of Proton Beam Therapy for Stage IV Pancreatic Adenocarcinoma.
Yamaguchi H; Kato T; Narita Y; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Kikuchi Y; Murakami M
Cureus; 2024 Apr; 16(4):e57771. PubMed ID: 38716033
[TBL] [Abstract][Full Text] [Related]
16. Hidden in plain sight: commonly missed early signs of pancreatic cancer on CT.
Ahmed TM; Chu LC; Javed AA; Yasrab M; Blanco A; Hruban RH; Fishman EK; Kawamoto S
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38782784
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative imaging features of solid pancreas tumours in portal venous phase CT: are they useful in determining tumour type and grade?
Gündoğdu E; Küçükhüseyin A
Pol J Radiol; 2024; 89():e140-e147. PubMed ID: 38550958
[TBL] [Abstract][Full Text] [Related]
18. Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 Investigation.
Meyer-Knees JW; Falkenthal J; Geisel D; Neumann CCM; Hilfenhaus G; Stephan LU; Schöning W; Malinka T; Pratschke J; Stintzing S; Pelzer U
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539528
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with radiological misstaging of pancreatic ductal adenocarcinoma: A retrospective observational study.
Yasrab M; Thakker S; Wright MJ; Ahmed T; He J; Wolfgang CL; Chu LC; Weiss MJ; Kawamoto S; Johnson PT; Fishman EK; Javed AA
Curr Probl Diagn Radiol; 2024 Mar; ():. PubMed ID: 38522966
[TBL] [Abstract][Full Text] [Related]
20. Trends and hotspots of prognostic factors for pancreatic ductal adenocarcinoma from 2013 to 2022.
Peng J; Lv M; Peng Y; Tang X
Hepatobiliary Surg Nutr; 2024 Apr; 13(2):370-373. PubMed ID: 38617492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
